<DOC>
	<DOC>NCT00618865</DOC>
	<brief_summary>Whether high-dose omega-3 fatty acids supplement would be an effective treatment in patients with major depressive disorder during pregnancy and breast-feeding.</brief_summary>
	<brief_title>Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<criteria>Eligible participants were pregnant women, aged 18 to 40 years, with major depressive disorder onset between their 16th week (second trimester) and 32nd week (third trimester) of gestation at the Department of Obstetrics. Subjects were excluded with a DSMIV diagnosis of bipolar disorders, psychotic disorders, substance abuse or dependence for at least 3 months, or any AxisII diagnosis of borderline or antisocial personality disorder.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Omega-3 Fatty Acids</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Women during pregnancy and after childbirth are more vulnerable to psychiatric disorders</keyword>
	<keyword>Pharmacotherapy for depression during pregnancy is a clinical dilemma.</keyword>
	<keyword>Omega-3 polyunsaturated fatty acids (PUFAs) might be a promising alternative of treatment for pregnant women with depression.</keyword>
</DOC>